Associations of serum carotenoid levels with serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in black men and white men

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 12, 2007, Pages 2781-2783

  Kim, Young L ^a   Jacobs Jr , David R ^d   Gross, Myron D ^e   Bergan, Raymond C ^a,b   Gann, Peter H ^c   Liu, Kiang ^a   Gapstur, Susan M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTENOID; LYCOPENE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIETARY INTAKE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CAROTENOIDS; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 38849147588     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0637     Document Type: Article

References (27)

1. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-31.
2. Heber D, Lu QY. Overview of mechanisms of action of lycopene. Exp Biol Med 2002;227:920-3.
3. Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of human cancer cell-proliferation than either α-carotene or β-carotene. Nutr Cancer 1995;24:257-66.
4. Karas M, Amir H, Fishman D, et al. Lycopene interferes with cell cycle progression and insulin-like growth factor 1 signaling in mammary cancer cells. Nutr Cancer 2000;36:101-11.
5. Kucuk O, Sarkar FH, Sakr W, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001;10:861-8.
6. Mucci LA, Tamimi R, Lagiou P, et al. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 2001;87:814-20.
7. Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor 1 and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002;11:852-61.
8. Gunnell D, Oliver SE, Donovan JL, et al. Are diet-prostate cancer associations mediated by insulin-like growth factors? Cross-sectional analysis of diet-IGF associations in middle-aged men. Cancer Epidemiol Biomarkers Prev 2002;11:1219-9s.
9. Liu C, Lian FZ, Smith DE, Russell RM, Wang XD. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 2003;63:3138-44.
10. Voskuil DW, Vrieling A, van't Veer LJ, Kampman E, Rookus MA. The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol Biomarkers Prev 2005;14:195-203.
11. Holly JMP, Gunnell DJ, Smith GD. Growth hormone, IGF-1 and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 1999;162:321-30.
12. Ali O, Cohen P, Lee KW. Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule. Horm Metab Res 2003;35:726-33.
13. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
14. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004;4:505-18.
15. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
16. Iribarren C, Jacobs DR, Kiefe CI, et al. Causes and demographic, medical, lifestyle and psychosocial predictors of premature mortality: the CARDIA Study. Soc Sci Med 2005;60:471-82.
17. Bieri JG, Brown ED, Smith JC. Determination of individual carotenoids in human plasma by high performance liquid chromatography. J Liq Chromatogr 1985;8:473-84.
18. Craft NE, Brown ED, Smith JC. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin Chem 1988;34:44-8.
19. Gross MD, Prouty CB, Jacobs DR. Stability of carotenoids and α-tocopherol during blood collection and processing procedures. Clin Chem 1995;41:943-4.
20. Iribarren C, Folsom AR, Jacobs DR, Gross MD, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vas Biol 1997;17:1171-7.
21. Colangelo LA, Liu K, Gapstur SM. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: the CARDIA Male Hormone Study. Am J Epidemiol 2004;160:750-7.
22. Colangelo LA, Chin BCH, Liu K, Kopp PA, Gann PH, Gapstur SM. IGF-1, IGFBP-3, and nutritional factors in young black and white men: the CARDIA Male Hormone Study. Nutr Cancer 2005;53:57-64.
23. Gapstur SM, Kopp P, Chiu BCH, Gann PH, Colangelo LA, Liu K. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-1 and IGF binding protein-3 levels in black and white men: the CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev 2004;13:2208-16.
24. Gross M, Yu XH, Hannan P, Prouty C, Jacobs DR. Lipid standardization of serum fat-soluble antioxidant concentrations: the YALTA Study. Am J Clin Nutr 2003;77:458-66.
25. Signorello LB, Kuper H, Lagiou P, et al. Lifestyle factors and insulin-like growth factor 1 levels among elderly men. Eur J Cancer Prev 2000;9:173-8.
26. Gunnell D, Oliver SE, Peters TJ, et al. Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-1 and IGFBP-3 in healthy middle-aged men. Brit J Cancer 2003;88:1682-6.
27. Vrieling A, Voskuil DW, de Mesquita HBB, et al. Dietary determinants of circulating insulin-like growth factor (IGF)-1 and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Cancer Causes Control 2004;15:787-96.